118 related articles for article (PubMed ID: 36227250)
61. Synthesis of 4,5-diaryl-1H-pyrazole-3-ol derivatives as potential COX-2 inhibitors.
Patel MV; Bell R; Majest S; Henry R; Kolasa T
J Org Chem; 2004 Oct; 69(21):7058-65. PubMed ID: 15471453
[TBL] [Abstract][Full Text] [Related]
62. Cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) selectivity of COX inhibitors.
Sud'ina GF; Pushkareva MA; Shephard P; Klein T
Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):99-108. PubMed ID: 18280718
[TBL] [Abstract][Full Text] [Related]
63. Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: Anti-inflammatory activity, histopatholgical profile and in-silico studies.
Abdellatif KRA; Abdelall EKA; Labib MB; Fadaly WAA; Zidan TH
Bioorg Chem; 2020 Dec; 105():104418. PubMed ID: 33166844
[TBL] [Abstract][Full Text] [Related]
64. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
[TBL] [Abstract][Full Text] [Related]
65. Pyrazoles containing thiophene, thienopyrimidine and thienotriazolopyrimidine as COX-2 selective inhibitors: Design, synthesis, in vivo anti-inflammatory activity, docking and in silico chemo-informatic studies.
El-Shoukrofy MS; Abd El Razik HA; AboulWafa OM; Bayad AE; El-Ashmawy IM
Bioorg Chem; 2019 Apr; 85():541-557. PubMed ID: 30807897
[TBL] [Abstract][Full Text] [Related]
66. Synthesis of celecoxib analogues possessing a N-difluoromethyl-1,2-dihydropyrid-2-one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
J Med Chem; 2009 Mar; 52(6):1525-9. PubMed ID: 19296694
[TBL] [Abstract][Full Text] [Related]
67. Isomeric acetoxy analogs of celecoxib and their evaluation as cyclooxygenase inhibitors.
Abdur Rahim M; Praveen Rao PN; Bhardwaj A; Kaur J; Huang Z; Knaus EE
Bioorg Med Chem Lett; 2011 Oct; 21(20):6074-80. PubMed ID: 21890358
[TBL] [Abstract][Full Text] [Related]
68. Synthesis and biological evaluations of novel isoxazoles and furoxan derivative as anti-inflammatory agents.
Abdelall EKA
Bioorg Chem; 2020 Jan; 94():103441. PubMed ID: 31859011
[TBL] [Abstract][Full Text] [Related]
69. 1-(4-Methane(amino)sulfonylphenyl)-3-(4-substituted-phenyl)-5-(4-trifluoromethylphenyl)-1H-2-pyrazolines/pyrazoles as potential anti-inflammatory agents.
Abdellatif KR; Elshemy HA; Azoz AA
Bioorg Chem; 2015 Dec; 63():13-23. PubMed ID: 26398140
[TBL] [Abstract][Full Text] [Related]
70. Divergent synthesis and evaluation of inhibitory activities against cyclooxygenases-1 and -2 of natural withasomnines and analogues.
Usami Y; Watanabe R; Fujino Y; Shibano M; Ishida C; Yoneyama H; Harusawa S; Ichikawa H
Chem Pharm Bull (Tokyo); 2012; 60(12):1550-60. PubMed ID: 23207635
[TBL] [Abstract][Full Text] [Related]
71. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives.
Chaaban I; Rizk OH; Ibrahim TM; Henen SS; El-Khawass EM; Bayad AE; El-Ashmawy IM; Nematalla HA
Bioorg Chem; 2018 Aug; 78():220-235. PubMed ID: 29602046
[TBL] [Abstract][Full Text] [Related]
72. Synthesis of pyrazoles and isoxazoles as potent alpha(v)beta3 receptor antagonists.
Penning TD; Khilevich A; Chen BB; Russell MA; Boys ML; Wang Y; Duffin T; Engleman VW; Finn MB; Freeman SK; Hanneke ML; Keene JL; Klover JA; Nickols GA; Nickols MA; Rader RK; Settle SL; Shannon KE; Steininger CN; Westlin MM; Westlin WF
Bioorg Med Chem Lett; 2006 Jun; 16(12):3156-61. PubMed ID: 16621534
[TBL] [Abstract][Full Text] [Related]
73. Quantitative structure activity relationship studies of diaryl furanones as selective COX-2 inhibitors.
Shahapurkar S; Pandya T; Kawathekar N; Chaturvedi SC
Eur J Med Chem; 2004 Oct; 39(10):899-904. PubMed ID: 15782440
[TBL] [Abstract][Full Text] [Related]
74. Quantitative structure activity relationship studies of diaryl furanones as selective COX-2 inhibitors.
Shahapurkar S; Pandya T; Kawathekar N; Chaturvedi SC
Eur J Med Chem; 2004 Apr; 39(4):383-8. PubMed ID: 15072847
[TBL] [Abstract][Full Text] [Related]
75. 1,2-Diaryl-2-hydroxyiminoethanones as dual COX-1 and β-amyloid aggregation inhibitors: biological evaluation and in silico study.
Irannejad H; Unsal Tan O; Ozadali K; Dadashpour S; Tuylu Kucukkilinc T; Ahangar N; Ahmadnejad M; Emami S
Chem Biol Drug Des; 2015 Apr; 85(4):494-503. PubMed ID: 25227162
[TBL] [Abstract][Full Text] [Related]
76. Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors.
Consalvi S; Alfonso S; Di Capua A; Poce G; Pirolli A; Sabatino M; Ragno R; Anzini M; Sartini S; La Motta C; Di Cesare Mannelli L; Ghelardini C; Biava M
Bioorg Med Chem; 2015 Feb; 23(4):810-20. PubMed ID: 25596758
[TBL] [Abstract][Full Text] [Related]
77. 1,3,4-Trisubstituted pyrazole analogues as promising anti-inflammatory agents.
Alegaon SG; Alagawadi KR; Garg MK; Dushyant K; Vinod D
Bioorg Chem; 2014 Jun; 54():51-9. PubMed ID: 24793214
[TBL] [Abstract][Full Text] [Related]
78. Exploring selectivity requirements for COX-2 versus COX-1 binding of 2-(5-phenyl-pyrazol-1-yl)-5-methanesulfonylpyridines using topological and physico-chemical parameters.
Chakraborty S; Sengupta C; Roy K
Indian J Biochem Biophys; 2005 Apr; 42(2):106-12. PubMed ID: 23923570
[TBL] [Abstract][Full Text] [Related]
79. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents.
Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
Bioorg Chem; 2018 Aug; 78():358-371. PubMed ID: 29627656
[TBL] [Abstract][Full Text] [Related]
80. Design and synthesis of pyrazole/isoxazole linked arylcinnamides as tubulin polymerization inhibitors and potential antiproliferative agents.
Kamal A; Shaik AB; Rao BB; Khan I; Bharath Kumar G; Jain N
Org Biomol Chem; 2015 Oct; 13(40):10162-78. PubMed ID: 26303171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
